{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:48:46Z","timestamp":1791208126122,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1124\/jpet.104.075903","type":"journal-article","created":{"date-parts":[[2005,1,15]],"date-time":"2005-01-15T01:38:26Z","timestamp":1105753106000},"page":"554-560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["Liver-Targeted Drug Delivery Using HepDirect  Prodrugs"],"prefix":"10.1016","volume":"312","author":[{"given":"Mark D.","family":"Erion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"van Poelje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deidre A.","family":"MacKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Colby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika C.","family":"Montag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Fujitaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Linemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.104.075903_bib1","doi-asserted-by":"crossref","unstructured":"Akerman ME, Chan WCW, Laakkonen P, Bhatia SN, and Ruoslahti E (2002) Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 99: 12617-12621.","DOI":"10.1073\/pnas.152463399"},{"key":"10.1124\/jpet.104.075903_bib2","doi-asserted-by":"crossref","unstructured":"Arap W, Pasqualini R, and Ruoslahti R (1998) Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science (Wash DC) 279: 377-380.","DOI":"10.1126\/science.279.5349.377"},{"key":"10.1124\/jpet.104.075903_bib3","doi-asserted-by":"crossref","unstructured":"Arner ES and Eriksson S (1995) Mammalian deoxyribonucleoside kinases. Pharmacol Ther 67: 155-186.","DOI":"10.1016\/0163-7258(95)00015-9"},{"key":"10.1124\/jpet.104.075903_bib4","doi-asserted-by":"crossref","unstructured":"Bagshawe KD (1987) Antibody directed enzymes revive anti-cancer prodrugs concept. Br J Cancer 56: 531-532.","DOI":"10.1038\/bjc.1987.237"},{"key":"10.1124\/jpet.104.075903_bib5","doi-asserted-by":"crossref","unstructured":"Baker MA, Cerniglia GJ, and Zaman A (1990) Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 190: 360-365.","DOI":"10.1016\/0003-2697(90)90208-Q"},{"key":"10.1124\/jpet.104.075903_bib6","doi-asserted-by":"crossref","unstructured":"Benzaria S, Pelicano H, Johnson R, Maury G, Imbach J-L, Aubertin A-M, Obert G, and Gosselin G (1996) Synthesis, in vitro antiviral evaluation, and stability studies of bis(S-acyl-2-thioethyl) ester derivatives of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) as potential PMEA prodrugs with improved oral bioavailability. J Med Chem 39: 4958-4965.","DOI":"10.1021\/jm960289o"},{"key":"10.1124\/jpet.104.075903_bib7","doi-asserted-by":"crossref","unstructured":"Berry MN and Friend DS (1969) High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 43: 506-520.","DOI":"10.1083\/jcb.43.3.506"},{"key":"10.1124\/jpet.104.075903_bib8","doi-asserted-by":"crossref","unstructured":"Bodor N, Farag HH and Brewster ME, III (1981) Site-specific, sustained release of drugs to the brain. Science (Wash DC) 214: 1370-1372.","DOI":"10.1126\/science.7313698"},{"key":"10.1124\/jpet.104.075903_bib9","doi-asserted-by":"crossref","unstructured":"Borst P, Balzarini J, Ono N, Reid G, de Vries H, Wielinga P, Wijnholds J, and Zelcer N (2004) The potential impact of drug transporters on nucleoside-analog-based antiviral chemotherapy. Antiviral Res 62: 1-7.","DOI":"10.1016\/j.antiviral.2003.11.002"},{"key":"10.1124\/jpet.104.075903_bib10","doi-asserted-by":"crossref","unstructured":"Camiener GW and Smith CG (1965) Studies of the enzymatic deamination of cytosine arabinoside. I. Enzyme distribution and species specificity. Biochem Pharmacol 14: 1405-1416.","DOI":"10.1016\/0006-2952(65)90175-9"},{"key":"10.1124\/jpet.104.075903_bib11","doi-asserted-by":"crossref","unstructured":"Dallas S, Schlichter L, and Bendayan R (2004) Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia. J Pharmacol Exp Ther 309: 1221-1229.","DOI":"10.1124\/jpet.103.063966"},{"key":"10.1124\/jpet.104.075903_bib12","doi-asserted-by":"crossref","unstructured":"de Waziers I, Cugnenc PH, Yang CS, Leroux JP, and Beaune PH (1990) Cytochrome P450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther 253: 387-394.","DOI":"10.1016\/S0022-3565(25)12474-9"},{"key":"10.1124\/jpet.104.075903_bib13","doi-asserted-by":"crossref","unstructured":"Dinkova-Kostova AT, Massiah MA, Bozak RE, Hicks RJ, and Talalay P (2001) Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc Natl Acad Sci USA 98: 3404-3409.","DOI":"10.1073\/pnas.051632198"},{"key":"10.1124\/jpet.104.075903_bib14","doi-asserted-by":"crossref","unstructured":"Erion MD, Reddy KR, Boyer SH, Matelich MC, Gomez-Galeno JG, Lemus RH, Ugarkar BG, Colby TJ, Schanzer J, and van Poelje PD (2004) Design, synthesis, and characterization of a series of cytochrome P450 3A-activated prodrugs (Hep-Direct prodrugs) useful for targeting phosph(on)ate-based drugs to the liver. J Am Chem Soc 126: 5154-5163.","DOI":"10.1021\/ja031818y"},{"key":"10.1124\/jpet.104.075903_bib15","doi-asserted-by":"crossref","unstructured":"Faber KN, Muller M, and Jansen PL (2003) Drug transport proteins in the liver. Adv Drug Delivery Rev 55: 107-124.","DOI":"10.1016\/S0169-409X(02)00173-4"},{"key":"10.1124\/jpet.104.075903_bib16","doi-asserted-by":"crossref","unstructured":"Fiume L, Bonino F, Mattioli A, Chiaberge E, Torrani Cerenzia MR, Busi C, Brunetto MR, and Verme G (1988) Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin. Lancet 2: 13-15.","DOI":"10.1016\/S0140-6736(88)92946-7"},{"key":"10.1124\/jpet.104.075903_bib17","doi-asserted-by":"crossref","unstructured":"Garrett C and Santi DV (1979) A rapid and sensitive high pressure liquid chromatography assay for deoxyribonucleoside triphosphates in cell extracts. Anal Biochem 99: 268-273.","DOI":"10.1016\/S0003-2697(79)80005-6"},{"key":"10.1124\/jpet.104.075903_bib18","doi-asserted-by":"crossref","unstructured":"Hales BF, Ludeman SM, and Boyd VL (1989) Embryotoxicity of phenyl ketone analogs of cyclophosphamide. Teratology 39: 31-37.","DOI":"10.1002\/tera.1420390105"},{"key":"10.1124\/jpet.104.075903_bib19","unstructured":"Heinemann V, Hertel LW, Grindey GB, and Plunkett W (1988) Comparison of the cellular pharmacokinetics and toxicity of 2\u2032,2\u2032-diflurodeoxycytidine and 1-\u03b2-D-arabinofuranosylcytosine. Cancer Res 48: 4024-4031."},{"key":"10.1124\/jpet.104.075903_bib20","doi-asserted-by":"crossref","unstructured":"Huber BE, Austin EA, Richards CA, Davis ST, and Good SS (1994) Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci USA 91: 8302-8306.","DOI":"10.1073\/pnas.91.17.8302"},{"key":"10.1124\/jpet.104.075903_bib21","doi-asserted-by":"crossref","unstructured":"Kramer W, Wess G, Schubert G, Bickel M, Girbig F, Gutahr U, Kowalewski S, Baringhaus K-H, Enhsen A, Glombik H, et al. (1992) Liver-specific drug targeting by coupling to bile acids. J Biol Chem 267: 18598-18604.","DOI":"10.1016\/S0021-9258(19)37003-6"},{"key":"10.1124\/jpet.104.075903_bib22","doi-asserted-by":"crossref","unstructured":"Lakehal F, Wendum D, Barbu V, Becquemont L, Poupon R, Balladur P, Hannoun L, Ballet F, Beaune PH, and Housset C (1999) Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium. Hepatology 30: 1498-1506.","DOI":"10.1002\/hep.510300619"},{"key":"10.1124\/jpet.104.075903_bib23","doi-asserted-by":"crossref","unstructured":"Marcellin P, Chang T-T, Lim SG, Tong MJ, Sievert W, Shiffman ML, Jeffers L, Goodman Z, Wulfsohn MS, Xiong S, et al. (2003) Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 348: 808-816.","DOI":"10.1056\/NEJMoa020681"},{"key":"10.1124\/jpet.104.075903_bib24","doi-asserted-by":"crossref","unstructured":"Meijer DKF and Molema G (1995) Targeting of drugs to the liver. Semin Liver Dis 15: 202-256.","DOI":"10.1055\/s-2007-1007278"},{"key":"10.1124\/jpet.104.075903_bib25","unstructured":"Meijer DKF, Molema G, Jansen RW, and Moolenaar F (1990) Design of cell-specific drug targeting preparations for the liver: where cell biology and medicinal chemistry meet, in Trends in Drug Research (Claassen V ed), vol 13, pp 303-332, Elsevier, Amsterdam."},{"key":"10.1124\/jpet.104.075903_bib26","unstructured":"Meister A (1983) Metabolism and transport of glutathione and other \u03b3-glutamyl compounds, in Functions of Glutathione: Biochemical, Physiological, Toxicological and Clinical Aspects (Larrson A, Orrenius AS, Halmgren A, and Mannervic B eds) pp 1-22, Raven Press, New York."},{"key":"10.1124\/jpet.104.075903_bib27","doi-asserted-by":"crossref","unstructured":"Milam KM and Byard JL (1985) Acetaminophen metabolism, cytotoxicity and genotoxicity in rat primary hepatocyte cultures. Toxicol Appl Pharmacol 79: 342-347.","DOI":"10.1016\/0041-008X(85)90356-4"},{"key":"10.1124\/jpet.104.075903_bib28","doi-asserted-by":"crossref","unstructured":"Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, and Brodie BB (1973) Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 187: 211-217.","DOI":"10.1016\/S0022-3565(25)29666-5"},{"key":"10.1124\/jpet.104.075903_bib29","doi-asserted-by":"crossref","unstructured":"Miura S and Izuta S (2004) DNA polymerases as targets of anticancer nucleosides. Curr Drug Targets 5: 191-195.","DOI":"10.2174\/1389450043490578"},{"key":"10.1124\/jpet.104.075903_bib30","doi-asserted-by":"crossref","unstructured":"Mulcahy RT, Gipp JJ, Schmidt JP, Joswig C, and Borch RF (1994) Nitrobenzyl phosphorodiamidates as potential hypoxia-selective alkylating agents. J Med Chem 37: 1610-1615.","DOI":"10.1021\/jm00037a011"},{"key":"10.1124\/jpet.104.075903_bib31","doi-asserted-by":"crossref","unstructured":"Neudecker T, Eder E, Deininger C, Hoffman C, and Henschler D (1989) Mutagenicity of methylvinyl ketone in Salmonella typhimurium TA100\u2013indication for epoxidation as an activation mechanism. Mutat Res 227: 131-134.","DOI":"10.1016\/0165-7992(89)90009-2"},{"key":"10.1124\/jpet.104.075903_bib32","doi-asserted-by":"crossref","unstructured":"Parola M, Robino G, Bordone R, Leonarduzzi G, Casini A, Pinzani M, Neve E, Bellomo G, Dianzani MU, Ingelman-Sundberg M, et al. (1997) Detection of cytochrome P4503A (CYP3A) in human hepatic stellate cells. Biochem Biophys Res Commun 238: 420-424.","DOI":"10.1006\/bbrc.1997.7307"},{"key":"10.1124\/jpet.104.075903_bib33","doi-asserted-by":"crossref","unstructured":"Payne G (2003) Progress in immunoconjugate cancer therapeutics. Cancer Cell 3: 207-212.","DOI":"10.1016\/S1535-6108(03)00057-6"},{"key":"10.1124\/jpet.104.075903_bib34","doi-asserted-by":"crossref","unstructured":"Ruoslahti E (2002) Drug targeting to specific vascular sites. Drug Discov Today 7: 1138-1143.","DOI":"10.1016\/S1359-6446(02)02501-1"},{"key":"10.1124\/jpet.104.075903_bib35","doi-asserted-by":"crossref","unstructured":"Stella VJ and Himmelstein KJ (1980) Prodrugs and site-specific drug delivery. J Med Chem 23: 1275-1282.","DOI":"10.1021\/jm00186a001"},{"key":"10.1124\/jpet.104.075903_bib36","doi-asserted-by":"crossref","unstructured":"Tomlinson E (1987) Theory and practice of site-specific drug delivery. Adv Drug Delivery Rev 1: 87-198.","DOI":"10.1016\/0169-409X(87)90001-9"},{"key":"10.1124\/jpet.104.075903_bib37","doi-asserted-by":"crossref","unstructured":"van Montfoort JE, Hagenbuch B, Groothuis GM, Koepsell H, Meier PJ, and Meijer DK (2003) Drug uptake systems in liver and kidney. Curr Drug Metab 4: 185-211.","DOI":"10.2174\/1389200033489460"},{"key":"10.1124\/jpet.104.075903_bib38","doi-asserted-by":"crossref","unstructured":"Williams FM (1985) Clinical significance of esterases in man. Clin Pharmacokinet 10: 392-403.","DOI":"10.2165\/00003088-198510050-00002"},{"key":"10.1124\/jpet.104.075903_bib39","doi-asserted-by":"crossref","unstructured":"Wu J, Nantz MH, and Zern MA (2002) Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications. Frontiers Biosci 7: 717-725.","DOI":"10.2741\/A806"},{"key":"10.1124\/jpet.104.075903_bib40","doi-asserted-by":"crossref","unstructured":"Zhang YJ, Chen S, Tsai WY, Ahsan H, Lunn RM, Wang LY, Chen CJ, and Santella RM (2000) Expression of cytochrome P450 1A1\/2 and 3A4 in liver tissues of hepatocellular carcinoma cases and controls from Taiwan and their relationship to hepatitis B virus and aflatoxin B1- and 4-aminobiphenyl-DNA adducts. Biomarkers 5: 295-306.","DOI":"10.1080\/135475000413845"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524317859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524317859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.104.075903","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:17:54Z","timestamp":1739999874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524317859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0022356524317859"],"URL":"https:\/\/doi.org\/10.1124\/jpet.104.075903","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver-Targeted Drug Delivery Using HepDirect Prodrugs","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.104.075903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}